SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Distributed Bio, a global leader in computational optimization of fully human monoclonal antibody libraries, is pleased to announce a comprehensive ...

WILMINGTON, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the Company will provide clients exclusive access to the new Cosmic ...

LONDON, UK / ACCESSWIRE / January 08, 2018 / Active-Investors.com has just released a free research report on Pfizer Inc. (NYSE: PFE). If you want access to this report all you need to do is sign up ...

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks ...

Distributed Bio CEO Jacob Glanville is actively working on a treatment for COVID-19. He joins Yahoo Finance’s On The Move panel to discuss how the antibodies their team acquired can be effective ...

This new partnership provides access to Distributed Bio’s antibody discovery platforms. Charles River Laboratories International announced on Oct. 25, 2018 that it has entered into an exclusive ...

CNBC's "Squawk on the Street" team discusses the possibility of a coronavirus cure with Jake Glanville, CEO of Distributed Bio. Got a confidential news tip? We want to hear from you. Sign up for free ...

Distributed Bio and Twist Bioscience have announced a collaboration to offer therapeutic antibody design and optimization services, as well as an exclusive G-protein coupled receptor (GPCR) targeting ...

Previous Distributed Bio discovery platforms have delivered sequence-unique binders to every target panned, including ion channels, ultra-specific pMHC complex binders, G-protein-coupled receptors ...